Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD

Overview of attention for article published in Frontiers in immunology, July 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 13 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 37,230 followers.

Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD https://t.co/169HHXLWG3

28 Jul 2022

Reply Repost Favourite

During acute episodes plasma C3 and C4 may help in distinguishing #nmosd versus #MOGAD. Important insights in indentifying biomarkers of #neuroinflammatory disease. https://t.co/MrEXHvydjt

13 Jul 2022

Reply Repost Favourite

RT @FrontImmunol: New Research: Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are A…

11 Jul 2022

Reply Repost Favourite

RT @FrontImmunol: New Research: Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are A…

11 Jul 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.